Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kyle Moran

CFO at Wave Life Sciences Ltd. (WVE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.2M

Reported trades

Filed Stock Type Shares Price Value Since
Feb 11SEC WVEWave Life Sciences Ltd. Sell 3,588134,385 held (−3%) $13.45 $48K -74.3%
Dec 10SEC WVEWave Life Sciences Ltd. Sell Plan 60,00089,218 held (−40%) $13.20 $792K -73.8%
Dec 10SEC WVEWave Life Sciences Ltd. Sell Plan 50,000139,218 held (−26%) $15.00 $750K -76.9%
Dec 10SEC WVEWave Life Sciences Ltd. Sell Plan 50,00089,218 held (−36%) $13.20 $660K -73.8%
Dec 10SEC WVEWave Life Sciences Ltd. Sell Plan 50,00089,218 held (−36%) $18.00 $900K -80.8%
Dec 10SEC WVEWave Life Sciences Ltd. Sell Plan 3689,218 held (−0%) $20.25 $729 -82.9%
Dec 10SEC WVEWave Life Sciences Ltd. Sell Plan 50,00090,365 held (−36%) $20.03 $1.0M -82.7%
  • Sell

    CFO Kyle Moran sold $792K of WVE at $13.20 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Moran sold $750K of WVE at $15.00 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Moran sold $660K of WVE at $13.20 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Moran sold $900K of WVE at $18.00 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Moran sold $729 of WVE at $20.25 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Moran sold $1.0M of WVE at $20.03 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.